Zoetis Shares Outstanding History
Below is a table of the Zoetis shares outstanding history going back to 3/22/2013:

Date ZTS Shares Outstanding
3/22/201399.02M
5/10/201399.02M
8/9/2013500.00M
11/8/2013500.01M
3/19/2014500.73M
5/9/2014501.02M
8/8/2014501.19M
11/7/2014501.32M
2/23/2015500.79M
5/1/2015499.96M
8/3/2015498.94M
11/2/2015497.92M
2/19/2016497.16M
4/29/2016496.20M
8/1/2016495.04M
10/31/2016493.83M
2/10/2017491.96M
4/28/2017490.80M
8/2/2017489.11M
10/26/2017487.29M
2/9/2018485.25M
7/27/2018481.82M
10/26/2018480.45M
2/8/2019478.77M
4/26/2019478.66M
8/2/2019477.56M
12/31/20182.27B
11/1/2019476.30M
2/7/2020474.93M
5/1/2020474.94M

Also see: ZTS Market Cap History
ZTS YTD Return
ZTS RSI
ZTS DMA
ZTS MACD
ZTS Technical Analysis
Zoetis Historical Shares Outstanding:
+24.65% CAGR
Zoetis Historical Shares Outstanding: +24.65% CAGR

Mouse over chart for data details
3/22/2013 ...5/1/2020
Zoetis is a holding company. Through its subsidiaries, Co. is engaged in the discovery, development, manufacture and commercialization of animal health medicines, vaccines, and diagnostic products with a focus on both livestock and companion animals. Co. operates in two segments: the United States and International. Co.'s main product categories are vaccines, anti-infectives, parasiticides, other pharmaceutical products, dermatology products, medicated feed additives, and animal health diagnostics. Co.'s other non-pharmaceutical product categories include nutritionals and agribusiness, as well as products and services including biodevices, genetic tests and precision livestock farming. We show 30 historical shares outstanding datapoints in our coverage of ZTS's shares outstanding history.

Understanding the changing numbers of Zoetis shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like Zoetis versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching Zoetis by allowing them to research Zoetis shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ZTS:
ZTS SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Zoetis (ZTS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ZYNE Shares Outstanding History
A Shares Outstanding History
AAC Shares Outstanding History
ABAX Shares Outstanding History
ABBV Shares Outstanding History
ABC Shares Outstanding History
ABEO Shares Outstanding History
ABIO Shares Outstanding History
ABMD Shares Outstanding History
ABT Shares Outstanding History
More Healthcare companies »

 

Zoetis Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.